PDP2 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 8.501200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
7.375200E-01
Normal-vs-Stage2
8.645000E-01
Normal-vs-Stage3
1.774780E-01
Normal-vs-Stage4
4.276000E-02
Stage1-vs-Stage2
8.955400E-01
Stage1-vs-Stage3
3.081600E-02
Stage1-vs-Stage4
9.020000E-03
Stage2-vs-Stage3
5.223400E-03
Stage2-vs-Stage4
5.537200E-03
Stage3-vs-Stage4
1.300450E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
8.638200E-01
Normal-vs-AfricanAmerican
4.708200E-01
Normal-vs-Asian
7.382200E-01
Caucasian-vs-AfricanAmerican
3.237200E-01
Caucasian-vs-Asian
2.985000E-01
AfricanAmerican-vs-Asian
1.832570E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
8.202200E-01
Normal-vs-Female
8.847400E-01
Male-vs-Female
7.451000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
9.103000E-01
Normal-vs-Age(41-60Yrs)
6.514400E-01
Normal-vs-Age(61-80Yrs)
9.527400E-01
Normal-vs-Age(81-100Yrs)
9.749200E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
5.823800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
8.642200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
9.077200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.182810E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
4.509200E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
9.754000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
9.901200E-01
Normal-vs-Daily Drinker
6.077000E-01
Normal-vs-Weekly Drinker
8.916400E-01
Normal-vs-Occasional Drinker
6.325200E-01
Normal-vs-Social Drinker
6.602600E-01
Non Drinker-vs-Daily Drinker
2.341200E-01
Non Drinker-vs-Weekly Drinker
7.882000E-01
Non Drinker-vs-Occasional Drinker
2.996400E-01
Non Drinker-vs-Social Drinker
3.501400E-01
Daily Drinker-vs-Weekly Drinker
2.907200E-01
Daily Drinker-vs-Occasional Drinker
6.077700E-02
Daily Drinker-vs-Social Drinker
8.443600E-02
Weekly Drinker-vs-Occasional Drinker
6.756400E-01
Weekly Drinker-vs-Social Drinker
7.144600E-01
Occasional Drinker-vs-Social Drinker
9.760800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.265380E-01
Normal-vs-Grade 2
5.195500E-02
Normal-vs-Grade 3
3.308100E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
2.638600E-01
Grade 1-vs-Grade 3
1.193770E-01
Grade 1-vs-Grade 4
1.265380E-01
Grade 2-vs-Grade 3
4.707200E-01
Grade 2-vs-Grade 4
5.195500E-02
Grade 3-vs-Grade 4
3.308100E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
9.336200E-01
Normal-vs-NonDiabetic
9.435200E-01
Diabetic-vs-NonDiabetic
6.206600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
9.961400E-01
Normal-vs-NoPancreatitis
9.153200E-01
Pancreatitis-vs-NoPancreatitis
8.290400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
7.921400E-01
Normal-vs-N1
8.445000E-01
N0-vs-N1
8.259400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
6.345400E-01
Normal-vs-TP53-NonMutant
6.156800E-01
TP53-Mutant-vs-TP53-NonMutant
7.980800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
